Medicare Enrolled
Dr. Grant Lewis, M.D.
Hematology & Oncology · Savannah, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lewis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lewis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lewis
Dr. Grant Lewis is a hematology & oncology specialist in Savannah, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lewis performed 2,078 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lewis received a total of $13,822 from 78 pharmaceutical and/or device companies across 805 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lewis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 25% volume in GA
$13,822 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,078
Medicare services
Top 25% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,156 | $90 | $366 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
462 | $58 | $259 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
151 | $132 | $516 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
97 | $90 | $296 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
63 | $58 | $206 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
35 | $30 | $158 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
35 | $53 | $258 |
| New patient office visit, complex (60-74 min) | 25 | $158 | $636 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $72 | $321 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $120 | $480 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $120 | $572 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$13,822
Total received (2018-2024)
Avg $1,975/year across 7 years
Top 24% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
805
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,001
2023
$1,957
2022
$1,908
2021
$619
2020
$552
2019
$2,795
2018
$2,991
Payments by company (2024)
PFIZER INC.
$324
Merck Sharp & Dohme LLC
$291
Novartis Pharmaceuticals Corporation
$266
E.R. Squibb & Sons, L.L.C.
$251
AstraZeneca Pharmaceuticals LP
$185
Janssen Biotech, Inc.
$143
Daiichi Sankyo Inc.
$123
Pharmacosmos Therapeutics Inc.
$115
Gilead Sciences, Inc.
$105
Eisai Inc.
$104
ABBVIE INC.
$94
BeiGene USA, Inc.
$68
Incyte Corporation
$64
ARRAY BIOPHARMA INC
$63
Regeneron Healthcare Solutions, Inc.
$61
GlaxoSmithKline, LLC.
$55
Alexion Pharmaceuticals, Inc.
$53
EMD Serono, Inc.
$50
Lilly USA, LLC
$49
Ipsen Biopharmaceuticals, Inc
$49
PUMA BIOTECHNOLOGY, INC.
$48
Genentech USA, Inc.
$40
Kite Pharma, Inc.
$40
Takeda Pharmaceuticals U.S.A., Inc.
$40
Bayer Healthcare Pharmaceuticals Inc.
$39
Aveo Pharmaceuticals, Inc.
$37
SERVIER PHARMACEUTICALS LLC
$36
Exelixis Inc.
$35
Rigel Pharmaceuticals, Inc.
$33
TAIHO ONCOLOGY, INC.
$28
Alnylam Pharmaceuticals Inc.
$25
Acrotech Biopharma Inc.
$20
Deciphera Pharmaceuticals Inc.
$20
Astellas Pharma US Inc
$19
SpringWorks Therapeutics, Inc.
$14
ADC Therapeutics America, Inc.
$14
Top 3 companies account for 29.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,470
E.R. Squibb & Sons, L.L.C.
$829
Amgen Inc.
$818
Genentech USA, Inc.
$744
AstraZeneca Pharmaceuticals LP
$731
Merck Sharp & Dohme Corporation
$704
PFIZER INC.
$689
Merck Sharp & Dohme LLC
$677
Janssen Biotech, Inc.
$483
Celgene Corporation
$411
Daiichi Sankyo Inc.
$364
Gilead Sciences, Inc.
$341
Bayer HealthCare Pharmaceuticals Inc.
$335
Astellas Pharma US Inc
$291
Lilly USA, LLC
$284
Incyte Corporation
$274
GENZYME CORPORATION
$272
Eisai Inc.
$246
Seagen Inc.
$224
EISAI INC.
$202
Takeda Pharmaceuticals U.S.A., Inc.
$191
Exelixis Inc.
$179
Seattle Genetics, Inc.
$169
Regeneron Healthcare Solutions, Inc.
$169
Pharmacosmos Therapeutics Inc.
$131
ARRAY BIOPHARMA INC
$127
ABBVIE INC.
$121
Puma Biotechnology, Inc.
$119
GlaxoSmithKline, LLC.
$115
PUMA BIOTECHNOLOGY, INC.
$107
Pharmacyclics LLC, An AbbVie Company
$101
BeiGene USA, Inc.
$100
Foundation Medicine, Inc.
$92
Ipsen Biopharmaceuticals, Inc
$91
Alexion Pharmaceuticals, Inc.
$85
Kite Pharma, Inc.
$83
Bayer Healthcare Pharmaceuticals Inc.
$79
AbbVie, Inc.
$75
Kyowa Kirin, Inc.
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$64
Acrotech Biopharma LLC
$63
EMD Serono, Inc.
$62
Taiho Oncology, Inc.
$57
Lexicon Pharmaceuticals, Inc.
$54
AMAG Pharmaceuticals, Inc.
$53
SERVIER PHARMACEUTICALS LLC
$52
Karyopharm Therapeutics Inc.
$52
TerSera Therapeutics LLC
$43
Mirati Therapeutics, Inc.
$38
Pharmacyclics LLC, an AbbVie Company
$38
Mylan Institutional Inc.
$38
SANOFI-AVENTIS U.S. LLC
$37
Aveo Pharmaceuticals, Inc.
$37
Jazz Pharmaceuticals Inc.
$37
G1 Therapeutics, Inc.
$36
Acrotech Biopharma Inc.
$34
Rigel Pharmaceuticals, Inc.
$33
Sun Pharmaceutical Industries Inc.
$31
ADC Therapeutics America, Inc.
$30
Teva Pharmaceuticals USA, Inc.
$28
TAIHO ONCOLOGY, INC.
$28
MEDIVATION FIELD SOLUTIONS LLC
$27
Alnylam Pharmaceuticals Inc.
$25
Deciphera Pharmaceuticals Inc.
$20
TESARO, Inc.
$19
Emmaus Medical, Inc.
$19
Octapharma USA, Inc.
$19
Agios Pharmaceuticals, Inc.
$18
CTI BioPharma Corp.
$17
RECORDATI_RARE_DISEASES_INC.
$17
Heron Therapeutics, Inc.
$16
Adaptive Biotechnologies Corporation
$15
Shire North American Group Inc
$14
SpringWorks Therapeutics, Inc.
$14
JAZZ PHARMACEUTICALS INC.
$13
Janssen Pharmaceuticals, Inc
$13
Helsinn Therapeutics (U.S.), Inc.
$12
Clovis Oncology, Inc.
$11
Top 3 companies account for 22.6% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRILINTA · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CERDELGA · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · ELIQUIS · ELITEK · EMPLICITI · EPKINLY · ERLEADA · Endari · Enhertu · Erleada · FARESTON · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MOVANTIK · MVASI · Monoferric · Morphabond ER · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · Onivyde · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PYRUKYND · Perjeta · Pomalyst · Prolia · QINLOCK · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZOLADEX · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
11
County median income
$69,575
Nearest hospital to ZIP centroid (approximate)
CANDLER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lewis is a clinical cardiology specialist, with above-average Medicare volume (top 25% in GA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lewis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lewis performed 1,156 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lewis receive payments from pharmaceutical companies?
Yes. Dr. Lewis received a total of $13,822 from 78 companies across 805 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lewis's costs compare to other hematology & oncology specialists in Savannah?
Dr. Lewis's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lewis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Savannah
Browse hematology & oncology specialists in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology